Press release
MedTech Breakthrough Recognizes STIM onTrack for Bone Growth Therapy as Best Patient Engagement Mobile App
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the STIM
About this update from Orthofix Medical Inc.
[{"type":"text","content":" LEWISVILLE, Texas--(BUSINESS WIRE)--\nOrthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the STIM onTrack™ mobile app was recognized as the “Best Patient Engagement Mobile App” by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230504005188/en/The STIM onTrack mobile app empowers patients to track the daily use of their bone growth therapy device to help them stay on schedule with their treatments. The app enables the sharing of treatment data and patient reported outcome measures with physicians to assist in monitoring progress and overall recovery status. (Photo: Business Wire)\nThe STIM onTrack mobile app works with Orthofix CervicalStim™, SpinalStim™, and PhysioStim™ Bone Growth Therapy devices. Designed for use with smartphones and other mobile devices, the app provides tools such as a daily treatment reminder to help patients adhere to their prescriptions and improve their clinical outcomes.\n\n\n“Orthofix was the first to bring to market a patient mobile app for bone growth stimulation devices,” said Kevin Kenny, President of Orthofix Global Spine. “We are pleased to accept this award from MedTech Breakthrough. Our dedicated team works hard every day to develop patient-focused technologies like the STIM onTrack app to deliver on our commitment to improving patients’ lives and delivering innovative, quality-driven solutions.”\n\n\n“The STIM onTrack mobile app redefines the recovery experience for patients,” said Jason Shallenberger, Vice President of Bone Growth Therapy U.S. Sales and Marketing. “The purpose of the app is to empower patients to take an active role in their recovery. We are very proud of the STIM onTrack app and the work that went into developing this tool to assist patients in their recovery efforts.”\n\n\nPatients can track the daily use of their bone growth therapy device to help them stay on schedule with their treatments. The app enables the sharing of treatment data and patient reported outcome measures with physicians to assist in monitoring progress and overall recovery status. Through the app, patient...